Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL).

Cassin R, Mattiello V, Viltadi M, D'Aliberti D, Piazza R, Gambacorti-Passerini C, Gianelli U, Neri A, Cortelezzi A, Reda G.

Hematol Oncol. 2019 May 18. doi: 10.1002/hon.2638. [Epub ahead of print]

PMID:
31102420
2.

Venetoclax penetrates in cerebrospinal fluid and may be effective in chronic lymphocytic leukemia with central nervous system involvement.

Reda G, Cassin R, Dovrtelova G, Matteo C, Giannotta J, D'Incalci M, Cortelezzi A, Zucchetti M.

Haematologica. 2019 May;104(5):e222-e223. doi: 10.3324/haematol.2018.213157. Epub 2019 Feb 14. No abstract available.

3.

IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia.

Reda G, Cassin R, Gentile M, Mauro FR, Giannarelli D, Fattizzo B, Barbieri M, Silvestris I, Fabris S, Morabito F, Neri A, Barcellini W, Cortelezzi A.

Leukemia. 2019 Jan 11. doi: 10.1038/s41375-018-0344-1. [Epub ahead of print] No abstract available.

PMID:
30635629
4.

Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia.

Reda G, Riva M, Fattizzo B, Cassin R, Giannarelli D, Pennisi M, Freyrie A, Cairoli R, Molteni A, Cortelezzi A.

Semin Hematol. 2018 Oct;55(4):202-208. doi: 10.1053/j.seminhematol.2018.02.005. Epub 2018 Feb 21. Review.

PMID:
30502848
5.

Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study.

Reda G, Fattizzo B, Cassin R, Mattiello V, Tonella T, Giannarelli D, Massari F, Cortelezzi A.

J Hematol Oncol. 2018 Jun 11;11(1):79. doi: 10.1186/s13045-018-0626-0.

6.

Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia.

Reda G, Cassin R, Artoni A, Fattizzo B, Lecchi A, La Marca S, Bucciarelli P, Levati GV, Peyvandi F, Cortelezzi A.

Br J Haematol. 2018 Dec;183(5):825-828. doi: 10.1111/bjh.15052. Epub 2018 Jan 7. No abstract available.

PMID:
29315493
7.

Multifactorial neutropenia in a patient with acute promyelocytic leukemia and associated large granular lymphocyte expansion: A case report.

Reda G, Fattizzo B, Cassin R, Flospergher E, Orofino N, Gianelli U, Barcellini W, Cortelezzi A.

Oncol Lett. 2017 Mar;13(3):1307-1310. doi: 10.3892/ol.2016.5549. Epub 2016 Dec 28.

8.

Chronic lymphocytic leukemia and prognostic models: A bridge between clinical and biological markers.

Reda G, Cassin R, Fattizzo B, Giannarelli D, Mattiello V, Barcellini W, Cortelezzi A.

Am J Hematol. 2017 Jul;92(7):E135-E137. doi: 10.1002/ajh.24755. Epub 2017 May 26. No abstract available.

9.

Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables.

Baldini M, Marcon A, Ulivieri FM, Seghezzi S, Cassin R, Messina C, Cappellini MD, Graziadei G.

Ann Hematol. 2017 Jun;96(6):995-1003. doi: 10.1007/s00277-017-2959-0. Epub 2017 Mar 20.

PMID:
28321531
10.

Biological and molecular characterization of a rare case of cutaneous Richter syndrome.

Reda G, Cassin R, Fabris S, Ciceri G, Fattizzo B, Sciumè M, Orofino N, Gianelli U, Neri A, Cortelezzi A.

Hematol Oncol. 2017 Dec;35(4):869-874. doi: 10.1002/hon.2327. Epub 2016 Jul 12.

PMID:
27400669
11.

Impact of noise in holography with extended references in the low signal regime.

Boutu W, Gauthier D, Ge X, Cassin R, Ducousso M, Gonzalez AI, Iwan B, Samaan J, Wang F, Kovačev M, Merdji H.

Opt Express. 2016 Mar 21;24(6):6318-27. doi: 10.1364/OE.24.006318.

PMID:
27136823
12.

Treating chronic lymphocytic leukemia with obinutuzumab: safety and efficacy considerations.

Reda G, Orofino N, Cassin R, Sciumè M, Fattizzo B, Cortelezzi A.

Expert Opin Drug Saf. 2016 Jun;15(6):865-73. doi: 10.1517/14740338.2016.1165665. Epub 2016 Apr 7. Review.

PMID:
26967902
13.

Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience.

Sciumè M, Vincenti D, Reda G, Orofino N, Cassin R, Giannarelli D, Gaidano G, Rossi D, Cortelezzi A.

Am J Hematol. 2015 Nov;90(11):970-4. doi: 10.1002/ajh.24127. Epub 2015 Aug 14.

14.

Beta-thalassaemia intermedia: evaluation of endocrine and bone complications.

Baldini M, Marcon A, Cassin R, Ulivieri FM, Spinelli D, Cappellini MD, Graziadei G.

Biomed Res Int. 2014;2014:174581. doi: 10.1155/2014/174581. Epub 2014 Jul 7.

15.

Successful treatment with imatinib in a patient with chronic eosinophilic leukemia not otherwise specified.

Iurlo A, Fracchiolla NS, Ferla V, Cassin R, Gottardi E, Beghini A, Gianelli U, Spinelli O, Cortelezzi A.

J Clin Oncol. 2014 Apr 1;32(10):e37-9. doi: 10.1200/JCO.2012.48.0665. Epub 2014 Jan 21. No abstract available.

PMID:
24449233
16.

Immunomodulatory drugs: new options for the treatment of myelodysplastic syndromes.

Castelli R, Cassin R, Cannavò A, Cugno M.

Clin Lymphoma Myeloma Leuk. 2013 Feb;13(1):1-7. doi: 10.1016/j.clml.2012.09.016. Epub 2012 Nov 13. Review.

PMID:
23153925
17.

Gene amplification and drug resistance in cultured animal cells.

Schimke RT, Beverley S, Brown P, Cassin R, Federspiel N, Gasser C, Hill A, Johnston R, Mariani B, Mosse E, et al.

Cancer Treat Rev. 1984 Mar;11 Suppl A:9-17. Review. No abstract available.

PMID:
6375865

Supplemental Content

Loading ...
Support Center